Nasdaq · CIK 0001314727
SONO Sonos Inc
Insider trading from SEC Form 4. Last filing 13 d ago. Close $17.26 on Oct 9, 2026, +36% from the 52-week low and -10% from the high.
Last 90 days
Net insider value
-$1.0M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
2
$1.0M by 1 insider
Insiders on file
13
with a Form 4 at this company
Price and insider trades, last year
SONOOct 9, 2026 · close 17.26
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Sonos Inc, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 13Weak | Karen Boone director sell | $848k 46,766 shares | -40% | - | |
| 11Weak | Karen Boone director sell | $154k 10,000 shares | -11% | - | |
| 0Weak | Joanna Coles director sell | $14k 905 shares | -4% | - |
Congressional trades
1 trade in SONO disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Trade | Asset | Reported range | Trade / filing date | Source |
|---|---|---|---|---|---|
Julie Johnson House · D-TX | Sale | SONO Sonos, Inc. - Common Stock | $1,001 to $15k | Mar 11, 2025 / Apr 14, 2025 34 days after the trade | Clerk |
Transactions
The last 80 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | Karen Boone director | MOption exercise Common Stock10b5-1 | +31,766 | $13.56 | $431k | 116,037 | 13 d ago |
| Sep 25, 2026 | Karen Boone director | SOpen-market sale Common Stock10b5-1 | -31,766 | $18.12 | $576k | 84,271 | 13 d ago |
| Sep 25, 2026 | Karen Boone director | SOpen-market sale Common Stock10b5-1 | -15,000 | $18.13 | $272k | 69,271 | 13 d ago |
| Sep 25, 2026 | Karen Boone director | MOption exercise Director Stock Option (Right to Buy)derivative10b5-1 | -31,766 | $0.00 | $0 | 0 | 13 d ago |
| Sep 1, 2026 | Karen Boone director | SOpen-market sale Common Stock10b5-1 | -10,000 | $15.39 | $154k | 84,271 | 38 d ago |
| Mar 13, 2025 | Thomas Conrad Interim CEO | MOption exercise Common Stock | +29,971 | - | - | 95,792 | Mar 17, 2025 |
| Mar 13, 2025 | Thomas Conrad Interim CEO | FTax withholding Common Stock | -10,364 | $11.69 | $121k | 85,428 | Mar 17, 2025 |
| Mar 13, 2025 | Thomas Conrad Interim CEO | MOption exercise Restricted Stock Unitsderivative | -29,971 | $0.00 | $0 | 119,884 | Mar 17, 2025 |
| Mar 11, 2025 | Karen Boone director | AGrant or award Common Stock | +15,427 | - | - | 81,546 | Mar 13, 2025 |
| Mar 11, 2025 | Joanna Coles director | AGrant or award Common Stock | +15,427 | - | - | 35,471 | Mar 13, 2025 |
| Mar 11, 2025 | Bracken Darrell director | AGrant or award Common Stock | +15,427 | - | - | 27,040 | Mar 13, 2025 |
| Mar 11, 2025 | Julius Genachowski director | AGrant or award Common Stock | +15,427 | - | - | 101,546 | Mar 13, 2025 |
| Feb 14, 2025 | Saori Casey Chief Financial Officer | MOption exercise Common Stock | +110,042 | - | - | 110,042 | Feb 19, 2025 |
| Feb 14, 2025 | Deirdre Findlay Chief Commercial Officer | MOption exercise Common Stock | +14,599 | - | - | 102,903 | Feb 19, 2025 |
| Feb 14, 2025 | Shamayne Braman Chief People Officer | MOption exercise Common Stock | +29,623 | - | - | 62,649 | Feb 19, 2025 |
| Feb 14, 2025 | Saori Casey Chief Financial Officer | FTax withholding Common Stock | -43,625 | $13.17 | $575k | 66,417 | Feb 19, 2025 |
| Feb 14, 2025 | Shamayne Braman Chief People Officer | FTax withholding Common Stock | -9,519 | $13.17 | $125k | 53,130 | Feb 19, 2025 |
| Feb 14, 2025 | Deirdre Findlay Chief Commercial Officer | FTax withholding Common Stock | -5,505 | $13.17 | $73k | 97,398 | Feb 19, 2025 |
| Feb 14, 2025 | Saori Casey Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -99,500 | $0.00 | $0 | 325,504 | Feb 19, 2025 |
| Feb 14, 2025 | Deirdre Findlay Chief Commercial Officer | MOption exercise Restricted Stock Unitsderivative | -14,599 | $0.00 | $0 | 136,771 | Feb 19, 2025 |
| Feb 14, 2025 | Shamayne Braman Chief People Officer | MOption exercise Restricted Stock Unitsderivative | -1,217 | $0.00 | $0 | 126,260 | Feb 19, 2025 |
| Feb 14, 2025 | Shamayne Braman Chief People Officer | MOption exercise Restricted Stock Unitsderivative | -15,935 | $0.00 | $0 | 110,325 | Feb 19, 2025 |
| Feb 14, 2025 | Saori Casey Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -10,542 | $0.00 | $0 | 314,962 | Feb 19, 2025 |
| Feb 14, 2025 | Shamayne Braman Chief People Officer | MOption exercise Restricted Stock Unitsderivative | -12,471 | $0.00 | $0 | 97,854 | Feb 19, 2025 |
| Feb 13, 2025 | Thomas Conrad Interim CEO | MOption exercise Common Stock | +29,971 | - | - | 76,185 | Feb 18, 2025 |
| Feb 13, 2025 | Thomas Conrad Interim CEO | FTax withholding Common Stock | -10,364 | $13.12 | $136k | 65,821 | Feb 18, 2025 |
| Feb 13, 2025 | Thomas Conrad Interim CEO | MOption exercise Restricted Stock Unitsderivative | -29,971 | $0.00 | $0 | 149,855 | Feb 18, 2025 |
| Jan 13, 2025 | Thomas Conrad Interim CEO | AGrant or award Restricted Stock Unitsderivative | +179,826 | $0.00 | $0 | 179,826 | Jan 15, 2025 |
| Nov 15, 2024 | Patrick Spence Chief Executive Officer | MOption exercise Common Stock | +42,360 | - | - | 1,102,887 | Nov 19, 2024 |
| Nov 15, 2024 | Nicholas Millington Chief Innovation Officer | MOption exercise Common Stock | +58,719 | - | - | 438,446 | Nov 19, 2024 |
| Nov 15, 2024 | Christopher Scott Mason Principal Accounting Officer | MOption exercise Common Stock | +5,516 | - | - | 184,733 | Nov 19, 2024 |
| Nov 15, 2024 | Edward P Lazarus Chief Legal & Strategy Officer | MOption exercise Common Stock | +12,934 | - | - | 345,363 | Nov 19, 2024 |
| Nov 15, 2024 | Deirdre Findlay Chief Commercial Officer | MOption exercise Common Stock | +92,973 | - | - | 123,601 | Nov 19, 2024 |
| Nov 15, 2024 | Saori Casey Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +126,504 | $0.00 | $0 | 425,004 | Nov 19, 2024 |
| Nov 15, 2024 | Maxime Bouvat-Merlin Chief Product Officer | MOption exercise Common Stock | +22,096 | - | - | 22,799 | Nov 19, 2024 |
| Nov 15, 2024 | Shamayne Braman Chief People Officer | MOption exercise Common Stock | +9,279 | - | - | 35,867 | Nov 19, 2024 |
| Nov 15, 2024 | Shamayne Braman Chief People Officer | FTax withholding Common Stock | -2,841 | $13.75 | $39k | 33,026 | Nov 19, 2024 |
| Nov 15, 2024 | Patrick Spence Chief Executive Officer | FTax withholding Common Stock | -22,244 | $13.75 | $306k | 1,080,643 | Nov 19, 2024 |
| Nov 15, 2024 | Nicholas Millington Chief Innovation Officer | FTax withholding Common Stock | -28,442 | $13.75 | $391k | 410,004 | Nov 19, 2024 |
| Nov 15, 2024 | Deirdre Findlay Chief Commercial Officer | FTax withholding Common Stock | -35,297 | $13.75 | $485k | 88,304 | Nov 19, 2024 |
| Nov 15, 2024 | Maxime Bouvat-Merlin Chief Product Officer | FTax withholding Common Stock | -11,061 | $13.75 | $152k | 11,738 | Nov 19, 2024 |
| Nov 15, 2024 | Edward P Lazarus Chief Legal & Strategy Officer | FTax withholding Common Stock | -6,513 | $13.75 | $90k | 338,850 | Nov 19, 2024 |
| Nov 15, 2024 | Christopher Scott Mason Principal Accounting Officer | FTax withholding Common Stock | -2,173 | $13.75 | $30k | 182,560 | Nov 19, 2024 |
| Nov 15, 2024 | Maxime Bouvat-Merlin Chief Product Officer | MOption exercise Restricted Stock Unitsderivative | -1,593 | $0.00 | $0 | 137,047 | Nov 19, 2024 |
| Nov 15, 2024 | Patrick Spence Chief Executive Officer | MOption exercise Restricted Stock Unitsderivative | -5,052 | $0.00 | $0 | 244,643 | Nov 19, 2024 |
| Nov 15, 2024 | Nicholas Millington Chief Innovation Officer | MOption exercise Restricted Stock Unitsderivative | -2,829 | $0.00 | $0 | 164,194 | Nov 19, 2024 |
| Nov 15, 2024 | Christopher Scott Mason Principal Accounting Officer | MOption exercise Restricted Stock Unitsderivative | -169 | $0.00 | $0 | 52,307 | Nov 19, 2024 |
| Nov 15, 2024 | Shamayne Braman Chief People Officer | MOption exercise Restricted Stock Unitsderivative | -1,218 | $0.00 | $0 | 82,629 | Nov 19, 2024 |
| Nov 15, 2024 | Edward P Lazarus Chief Legal & Strategy Officer | MOption exercise Restricted Stock Unitsderivative | -1,752 | $0.00 | $0 | 109,734 | Nov 19, 2024 |
| Nov 15, 2024 | Deirdre Findlay Chief Commercial Officer | MOption exercise Restricted Stock Unitsderivative | -34,577 | $0.00 | $0 | 209,766 | Nov 19, 2024 |
| Nov 15, 2024 | Edward P Lazarus Chief Legal & Strategy Officer | MOption exercise Restricted Stock Unitsderivative | -2,223 | $0.00 | $0 | 107,511 | Nov 19, 2024 |
| Nov 15, 2024 | Patrick Spence Chief Executive Officer | MOption exercise Restricted Stock Unitsderivative | -4,684 | $0.00 | $0 | 239,959 | Nov 19, 2024 |
| Nov 15, 2024 | Shamayne Braman Chief People Officer | MOption exercise Restricted Stock Unitsderivative | -8,061 | $0.00 | $0 | 74,568 | Nov 19, 2024 |
| Nov 15, 2024 | Maxime Bouvat-Merlin Chief Product Officer | MOption exercise Restricted Stock Unitsderivative | -3,144 | $0.00 | $0 | 133,903 | Nov 19, 2024 |
| Nov 15, 2024 | Christopher Scott Mason Principal Accounting Officer | MOption exercise Restricted Stock Unitsderivative | -1,712 | $0.00 | $0 | 50,595 | Nov 19, 2024 |
| Nov 15, 2024 | Deirdre Findlay Chief Commercial Officer | MOption exercise Restricted Stock Unitsderivative | -58,396 | $0.00 | $0 | 151,370 | Nov 19, 2024 |
| Nov 15, 2024 | Nicholas Millington Chief Innovation Officer | MOption exercise Restricted Stock Unitsderivative | -9,788 | $0.00 | $0 | 154,406 | Nov 19, 2024 |
| Nov 15, 2024 | Patrick Spence Chief Executive Officer | MOption exercise Restricted Stock Unitsderivative | -32,624 | $0.00 | $0 | 207,335 | Nov 19, 2024 |
| Nov 15, 2024 | Shamayne Braman Chief People Officer | AGrant or award Restricted Stock Unitsderivative | +52,909 | $0.00 | $0 | 127,477 | Nov 19, 2024 |
| Nov 15, 2024 | Nicholas Millington Chief Innovation Officer | MOption exercise Restricted Stock Unitsderivative | -46,102 | $0.00 | $0 | 108,304 | Nov 19, 2024 |
| Nov 15, 2024 | Maxime Bouvat-Merlin Chief Product Officer | MOption exercise Restricted Stock Unitsderivative | -17,359 | $0.00 | $0 | 116,544 | Nov 19, 2024 |
| Nov 15, 2024 | Christopher Scott Mason Principal Accounting Officer | MOption exercise Restricted Stock Unitsderivative | -3,635 | $0.00 | $0 | 46,960 | Nov 19, 2024 |
| Nov 15, 2024 | Edward P Lazarus Chief Legal & Strategy Officer | MOption exercise Restricted Stock Unitsderivative | -8,959 | $0.00 | $0 | 98,552 | Nov 19, 2024 |
| Nov 15, 2024 | Maxime Bouvat-Merlin Chief Product Officer | AGrant or award Restricted Stock Unitsderivative | +52,909 | $0.00 | $0 | 169,453 | Nov 19, 2024 |
| Nov 15, 2024 | Christopher Scott Mason Principal Accounting Officer | AGrant or award Restricted Stock Unitsderivative | +58,174 | $0.00 | $0 | 105,134 | Nov 19, 2024 |
| Nov 15, 2024 | Nicholas Millington Chief Innovation Officer | AGrant or award Restricted Stock Unitsderivative | +56,688 | $0.00 | $0 | 164,992 | Nov 19, 2024 |
| Nov 15, 2024 | Patrick Spence Chief Executive Officer | AGrant or award Restricted Stock Unitsderivative | +188,958 | $0.00 | $0 | 396,293 | Nov 19, 2024 |
| Nov 15, 2024 | Edward P Lazarus Chief Legal & Strategy Officer | AGrant or award Restricted Stock Unitsderivative | +122,823 | $0.00 | $0 | 221,375 | Nov 19, 2024 |
| Nov 15, 2024 | Christopher Scott Mason Principal Accounting Officer | AGrant or award Restricted Stock Unitsderivative | +20,777 | $0.00 | $0 | 125,911 | Nov 19, 2024 |
| Nov 15, 2024 | Edward P Lazarus Chief Legal & Strategy Officer | AGrant or award Restricted Stock Unitsderivative | +151,167 | $0.00 | $0 | 372,542 | Nov 19, 2024 |
| Nov 14, 2024 | Joanna Coles director | SOpen-market sale Common Stock10b5-1 | -905 | $15.45 | $14k | 20,044 | Nov 15, 2024 |
| Nov 1, 2024 | Maxime Bouvat-Merlin Chief Product Officer | MOption exercise Common Stock | +1,427 | - | - | 1,427 | Nov 5, 2024 |
| Nov 1, 2024 | Edward P Lazarus Chief Legal & Strategy Officer | MOption exercise Common Stock | +1,570 | - | - | 333,225 | Nov 5, 2024 |
| Nov 1, 2024 | Patrick Spence Chief Executive Officer | MOption exercise Common Stock | +4,197 | - | - | 1,062,771 | Nov 5, 2024 |
| Nov 1, 2024 | Maxime Bouvat-Merlin Chief Product Officer | FTax withholding Common Stock | -724 | $12.53 | $9,072 | 703 | Nov 5, 2024 |
| Nov 1, 2024 | Edward P Lazarus Chief Legal & Strategy Officer | FTax withholding Common Stock | -796 | $12.53 | $9,974 | 332,429 | Nov 5, 2024 |
| Nov 1, 2024 | Patrick Spence Chief Executive Officer | FTax withholding Common Stock | -2,244 | $12.53 | $28k | 1,060,527 | Nov 5, 2024 |
| Nov 1, 2024 | Maxime Bouvat-Merlin Chief Product Officer | MOption exercise Performance Share Unitsderivative | -1,427 | $0.00 | $0 | 0 | Nov 5, 2024 |
| Nov 1, 2024 | Edward P Lazarus Chief Legal & Strategy Officer | MOption exercise Performance Share Unitsderivative | -1,570 | $0.00 | $0 | 0 | Nov 5, 2024 |
| Nov 1, 2024 | Patrick Spence Chief Executive Officer | MOption exercise Performance Share Unitsderivative | -4,197 | $0.00 | $0 | 0 | Nov 5, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Karen Booneceo, president, officer, director
- Maxime Bouvat-MerlinChief Product Officer
- Shamayne BramanChief People Officer
- Saori CaseyChief Financial Officer
- Joanna Colesdirector
- Thomas ConradInterim CEO
- Bracken Darrelldirector
- Deirdre FindlayChief Commercial Officer
- Julius Genachowskidirector
- Edward P LazarusChief Legal & Strategy Officer
- Christopher Scott MasonPrincipal Accounting Officer
- Nicholas MillingtonChief Innovation Officer
- Patrick SpenceChief Executive Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.